loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 26081 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Cayman Pharma s.r.o

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Aspen API. More than just an API.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Cayman Pharma s.r.o (1)

    filter

    01 LATANOPROST (1)

    filter

    01 Czech Republic (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CAYMAN PHARMA SRO

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothCayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
    Contact Supplier Contact Supplier
    Flag Czech Republic
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    LATANOPROST

    PDF Supplier PDF
    URL Supplier Web Content
    26081
    Active
    2012-05-14
    Complete
    2017-03-17
    2016-11-10
    II
    Cayman

    BIO Int. Convention

    Booth# 3740

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 26081 of Cayman Pharma Sro

    Looking for Drug Master Files (DMF) for 26081 of Cayman Pharma Sro 1

    20

    Cayman Pharma Sro, based in Czech Republic, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.

    One of their notable products is LATANOPROST, with a corresponding US DMF Number 26081.

    Remarkably, this DMF maintains an Active status since its submission on May 14, 2012, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of March 17, 2017, and payment made on November 10, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY